Nelson Sonja
CFO at Ambrx Biopharma, Inc.; Chief Financial Officer at IBRX
- Sold, on record
- $906k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Oct 27, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Ambrx Biopharma, Inc.CFO
- IBRXImmunityBio, Inc.Chief Financial Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- IBRX55,635 shares
- Ambrx Biopharma, Inc.12,778 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale IBRXUnusualJan 4, 2021 2021
Sold 39,271 shares at $13.62 ($535k)
Nelson Sonja, Chief Financial Officer
Sold 65.8% of holdings ($813k position)20,410 shares leftFirst sale on recordFiling
- 2 Form 4 sale IBRXUnusualJan 12, 2021 +8 days
Sold 16,364 shares at $15.00 ($245k)
Nelson Sonja, Chief Financial Officer
Sold 51.5% of holdings ($477k position)15,410 shares leftFiling
- 3 Form 144 notice Ambrx Biopharma, Inc.NoticeOct 27, 2023 +1018 days
Filed to sell 12,778 shares ($125k)
Nelson Sonja, CFO
No 10b5-1 planFirst sale on recordFiling
- 4 Form 4 sale Ambrx Biopharma, Inc.RoutineOct 27, 2023 same day
Sold 12,778 shares at $9.82 ($125k)
Nelson Sonja, Chief Financial Officer
10b5-1 planSold 8.9% of holdings ($1.4M position)130,079 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2023 | Oct 31, 2023 | Ambrx Biopharma, Inc. | Chief Financial Officer | Form 4 sale | 12,778 | $125k | 8.9% | Routine | SEC |
| Oct 27, 2023 | Oct 27, 2023 | Ambrx Biopharma, Inc. | CFO | Form 144 notice | 12,778 | $125k | Notice | SEC | |
| Jan 12, 2021 | Jan 13, 2021 | IBRX | Chief Financial Officer | Form 4 sale | 16,364 | $245k | 51.5% | Unusual | SEC |
| Jan 4, 2021 | Jan 6, 2021 | IBRX | Chief Financial Officer | Form 4 sale | 39,271 | $535k | 65.8% | Unusual | SEC |